Deltec Asset Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Deltec Asset Management’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-75,000	Closed	-$1.41M	–	200
2019 Q3	$1.41M	Buy	+75,000	New	+$858K	0.36%	54

Deltec Asset Management's ALDR Position: Q4 2019 in Review

Deltec Asset Management sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 75,000 shares — an estimated $1.41M sold.

Deltec Asset Management first reported a position in ALDR in Q3 2019 and held it in 1 quarter. The position peaked at $1.41M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Deltec Asset Management reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Deltec Asset Management sold 75,000 Alder Biopharmaceuticals shares in Q4 2019, an estimated $1.41M.
Deltec Asset Management first reported a position in Alder Biopharmaceuticals in Q3 2019 and held it in 1 quarter.
Deltec Asset Management's Alder Biopharmaceuticals position peaked at $1.41M in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Deltec Asset Management's 13F filing for Q4 2019, filed 27 Jan 2020.